TherapeuticsMD Inc

NASDAQ:TXMDUnited States

TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).

Contact Information

Headquarters

951 Yamato Road, Suite 220BOCA RATON, FL, United States 33431

Phone

561-961-1900

Fax

---

Executives

Executive Chairman of the Board

Thomas Thompson

Chief Executive Officer

Marlan Walker

Principal Financial Officer, Principal Accounting Officer

Joseph Ziegler

Independent Director

Cooper Collins

Independent Director

Gail Naughton